Sunzen Biotech Bhd (0148) — Cash Flow Quality Index
Sunzen Biotech Bhd (0148) has a Cash Flow Quality Index of 2.11x as of September 2023. Operating cash flow of RM3.58 Million exceeds net income of RM1.69 Million, indicating high earnings quality where cash backs reported profits. Also explore total assets of Sunzen Biotech Bhd for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sunzen Biotech Bhd Cash Flow Quality Index (2017–2023)
Historical Cash Flow Quality Index for Sunzen Biotech Bhd across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Sunzen Biotech Bhd's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sunzen Biotech Bhd (2017–2023)
Year-by-year earnings quality comparison for Sunzen Biotech Bhd. For live market cap and the full company financial profile, see market value of Sunzen Biotech Bhd.
| Year | Quality Index | Operating CF (MYR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.12x | RM819.39K | RM6.80 Million | ▲ +101.4% |
| 2022 | -8.55x | RM-32.06 Million | RM3.75 Million | ▲ +64.4% |
| 2021 | -24.05x | RM-16.36 Million | RM680.13K | ▼ -2500.6% |
| 2017 | 1.00x | RM4.02 Million | RM4.01 Million | — |